Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Didier Frappaz

Showing results (51-60 of 121) with videos related to

Pageof 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumorsGilles Vassal, Francois Doz, Didier Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric OncologyLaurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Frontiers in Neurology|June 20, 2022
Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II ProtocolPierre Leblond, Maura Massimino, Martin English, et al.
Oncotarget|March 9, 2018
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progressionGregorio J Petrirena, Julien Masliah-Planchon, Quentin Sala, et al.
Cancer|June 2, 2007
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapyVita Ridola, Jacques Grill, Francois Doz, et al.
Journal of Negative Results in Biomedicine|June 2, 2011
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsDavid W Ellison, Mehmet Kocak, Dominique Figarella-Branger, et al.
The Lancet. Oncology|August 11, 2012
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialAnnika Malmström, Bjørn Henning Grønberg, Christine Marosi, et al.
Bulletin Du Cancer|May 28, 2017
[Recommendations for the organ donation from patients with brain or medullary primitive tumors on behalf of the Association of the Neuro-oncologists of French Expression (ANOCEF) and the Club of Neuro-oncology of the French Society of Neurosurgery]Didier Frappaz, Emilie Le Rhun, Arnaud Dagain, et al.
Neuro-Oncology|December 2, 2017
EANO guidelines for the diagnosis and treatment of ependymal tumorsRoberta Rudà, Guido Reifenberger, Didier Frappaz, et al.
Bulletin Du Cancer|November 22, 2016
[Adolescent and Young Adults (AYAS) brain tumor national Web conference. On behalf of ANOCEF, GO-AJA and SFCE societies]Didier Frappaz, Marie-Pierre Sunyach, Emilie Le Rhun, et al.
Pageof 13

Showing results (51-60 of 121) with videos related to

Sort By:
Pageof 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 11, 2003
A phase I study of irinotecan as a 3-week schedule in children with refractory or recurrent solid tumorsGilles Vassal, Francois Doz, Didier Frappaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2009
Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric OncologyLaurence Brugières, Helene Pacquement, Marie-Cecile Le Deley, et al.
Frontiers in Neurology|June 20, 2022
Toward Improved Diagnosis Accuracy and Treatment of Children, Adolescents, and Young Adults With Ependymoma: The International SIOP Ependymoma II ProtocolPierre Leblond, Maura Massimino, Martin English, et al.
Oncotarget|March 9, 2018
Recurrent extraneural sonic hedgehog medulloblastoma exhibiting sustained response to vismodegib and temozolomide monotherapies and inter-metastatic molecular heterogeneity at progressionGregorio J Petrirena, Julien Masliah-Planchon, Quentin Sala, et al.
Cancer|June 2, 2007
High-dose chemotherapy with autologous stem cell rescue followed by posterior fossa irradiation for local medulloblastoma recurrence or progression after conventional chemotherapyVita Ridola, Jacques Grill, Francois Doz, et al.
Journal of Negative Results in Biomedicine|June 2, 2011
Histopathological grading of pediatric ependymoma: reproducibility and clinical relevance in European trial cohortsDavid W Ellison, Mehmet Kocak, Dominique Figarella-Branger, et al.
The Lancet. Oncology|August 11, 2012
Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trialAnnika Malmström, Bjørn Henning Grønberg, Christine Marosi, et al.
Bulletin Du Cancer|May 28, 2017
[Recommendations for the organ donation from patients with brain or medullary primitive tumors on behalf of the Association of the Neuro-oncologists of French Expression (ANOCEF) and the Club of Neuro-oncology of the French Society of Neurosurgery]Didier Frappaz, Emilie Le Rhun, Arnaud Dagain, et al.
Neuro-Oncology|December 2, 2017
EANO guidelines for the diagnosis and treatment of ependymal tumorsRoberta Rudà, Guido Reifenberger, Didier Frappaz, et al.
Bulletin Du Cancer|November 22, 2016
[Adolescent and Young Adults (AYAS) brain tumor national Web conference. On behalf of ANOCEF, GO-AJA and SFCE societies]Didier Frappaz, Marie-Pierre Sunyach, Emilie Le Rhun, et al.
Pageof 13